REG - Aberdeen Equity Inc - Issue of Equity

Aberdeen Equity Income TrustAnnouncement

16/01/2026 17:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260116:nRSP3098Pa&default-theme=true

RNS Number : 3098P  Aberdeen Equity Income Trust plc  16 January 2026

ABERDEEN EQUITY INCOME TRUST PLC

Legal Entity Identifier (LEI): 21380015XPT7BZISSQ74

 

16 January 2026

 

Issue of Equity

 

The Board of Aberdeen Equity Income Trust plc ("the Company") announces that
on 16 January 2026 the Company sold 132,245 Ordinary shares of 25
pence each from treasury at a price of 416.50 pence per Ordinary share and
allotted 167,755 Ordinary shares of 25 pence each, from the Company's general
business purposes blocklisting facility at a price of 416.50 pence per
Ordinary share. These Ordinary shares will rank pari passu with the existing
Ordinary shares in issue and dealings are expected to commence on 20 January
2026.

 

Following this issue, the Company has the ability to issue 4,610,397 Ordinary
shares under its blocklisting facilities.

 

Following these transactions the Company's issued share capital consists of
49,346,522 Ordinary shares, of which nil Ordinary shares are held in treasury.
Therefore, the total number of shares with voting rights in Aberdeen Equity
Income Trust PLC is 49,346,522 Ordinary shares.

 

The above figure of 49,346,522 Ordinary shares may be used by shareholders as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, Aberdeen Equity Income Trust PLC under the FCA's Disclosure Guidance and
Transparency Rules.

 

 

For further information, please contact:

 

Helen Leslie

abrdn Holdings Limited

Secretaries

 

Tel. 0131 372 9153

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFLFFDLFIRLIR



            Copyright 2019 Regulatory News Service, all rights reserved